113 related articles for article (PubMed ID: 8560451)
1. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].
Arnett KL; Adams EJ; Gumperz JE; Darke C; Marsh SG; Gelsthorpe K; Parham P
Tissue Antigens; 1995 Oct; 46(4):316-21. PubMed ID: 8560451
[TBL] [Abstract][Full Text] [Related]
2. Serological and molecular identification of an HLA-B8 variant, HLA-B8Jon (B*0802).
Darke C; Fussell H; Street J; Thomas M; Guttridge MG; Worwood M
Exp Clin Immunogenet; 1996; 13(3-4):139-53. PubMed ID: 9165268
[TBL] [Abstract][Full Text] [Related]
3. The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.
Saunders PM; Vivian JP; Baschuk N; Beddoe T; Widjaja J; O'Connor GM; Hitchen C; Pymm P; Andrews DM; Gras S; McVicar DW; Rossjohn J; Brooks AG
J Immunol; 2015 Jan; 194(2):781-789. PubMed ID: 25480565
[TBL] [Abstract][Full Text] [Related]
4. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
[TBL] [Abstract][Full Text] [Related]
5. Unexpected Bw4 and Bw6 reactivity patterns in new alleles.
Voorter CE; van der Vlies S; Kik M; van den Berg-Loonen EM
Tissue Antigens; 2000 Oct; 56(4):363-70. PubMed ID: 11098937
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structural modelling and calculation of electrostatic potentials of HLA Bw4 and Bw6 epitopes to explain the molecular basis for alloantibody binding: toward predicting HLA antigenicity and immunogenicity.
Mallon DH; Bradley JA; Winn PJ; Taylor CJ; Kosmoliaptsis V
Transplantation; 2015 Feb; 99(2):385-90. PubMed ID: 25606786
[TBL] [Abstract][Full Text] [Related]
7. Mapping of an epitope defined by a human hybridoma antibody (TrD3): a new HLA-B supertype associated with a subset of HLA-Bw6.
Kolstad A; Toubert A; Weyl D; Jun G; Hannestad K
Hum Immunol; 1992 Jun; 34(2):77-84. PubMed ID: 1385373
[TBL] [Abstract][Full Text] [Related]
8. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.
Lutz CT
Curr Opin Organ Transplant; 2014 Aug; 19(4):436-41. PubMed ID: 24977435
[TBL] [Abstract][Full Text] [Related]
10. The Bw4/Bw6 difference between HLA-B*0802 and HLA-B*0801 changes the peptides endogenously bound and the stimulation of alloreactive T cells.
Arnett KL; Huang W; Valiante NM; Barber LD; Parham P
Immunogenetics; 1998 Jun; 48(1):56-61. PubMed ID: 9601944
[TBL] [Abstract][Full Text] [Related]
11. Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.
Müller CA; Engler-Blum G; Gekeler V; Steiert I; Weiss E; Schmidt H
Immunogenetics; 1989; 30(3):200-7. PubMed ID: 2777338
[TBL] [Abstract][Full Text] [Related]
12. T cell can recognize the allospecificities formed by the substitution of amino acids associated with HLA-Bw4/Bw6 public epitopes.
Hiraiwa M; Yamamoto J; Matsumoto K; Karaki S; Nagao T; Kano K; Takiguchi M
Hum Immunol; 1991 Sep; 32(1):41-5. PubMed ID: 1723061
[TBL] [Abstract][Full Text] [Related]
13. HLA-B15: a widespread and diverse family of HLA-B alleles.
Hildebrand WH; Domena JD; Shen SY; Lau M; Terasaki PI; Bunce M; Marsh SG; Guttridge MG; Bias WB; Parham P
Tissue Antigens; 1994 Apr; 43(4):209-18. PubMed ID: 7521976
[TBL] [Abstract][Full Text] [Related]
14. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
[TBL] [Abstract][Full Text] [Related]
15. Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.
Ugolotti E; Vanni I; Raso A; Benzi F; Malnati M; Biassoni R
Hum Immunol; 2011 Oct; 72(10):859-68. PubMed ID: 21664941
[TBL] [Abstract][Full Text] [Related]
16. Serological mapping of HLA-epitopes with monoclonal antibodies and its interpretation by sequenced HLA-molecules.
Harpprecht J; Olde K; Westphal E; Müller-Ruchholtz W
Tissue Antigens; 1989 Sep; 34(3):170-8. PubMed ID: 2480657
[TBL] [Abstract][Full Text] [Related]
17. Nucleotide sequence analysis of HLA-B*1523 and B*8101. Dominant alpha-helical motifs produce complex serologic recognition patterns for the HLA-B"DT" and HLA-B"NM5" antigens.
Ellexson ME; Zhang G; Stewart D; Lau M; Teresi G; Terasaki P; Roe B; Hildebrand W
Hum Immunol; 1995 Oct; 44(2):103-10. PubMed ID: 8847228
[TBL] [Abstract][Full Text] [Related]
18. A public HLA antigen associated with HLA-A9, Aw32, and Bw4.
Kostyu DD; Cresswell P; Amos DB
Immunogenetics; 1980; 10(5):433-42. PubMed ID: 22457917
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a new HLA-B18 allele, B*1806, which lacks expression of the Bw6 epitope.
Balas A; García-Sánchez F; Santos S; Lillo R; Merino JL; Vicario JL
Tissue Antigens; 1998 Dec; 52(6):579-82. PubMed ID: 9894858
[TBL] [Abstract][Full Text] [Related]
20. Association of Bw4/Bw6 mismatch across class I HLA loci with renal graft outcomes in first time transplants.
Tang MS; Wang M; Chang SH; Alhamad T; Liu C
Hum Immunol; 2021 Oct; 82(10):767-774. PubMed ID: 34362574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
